Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy

S J Luen, R Salgado, M V Dieci, A Vingiani, G Curigliano, R E Gould, C Castaneda, T D'Alfonso, J Sanchez, E Cheng, E Andreopoulou, M Castillo, S Adams, S Demaria, W F Symmans, S Michiels, S Loi

Research output: Contribution to journalArticle

Abstract

Background: For primary triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NAC), higher pre-treatment tumor-infiltrating lymphocytes (TILs) correlates with increased pathological complete response (pCR) rates, and improved survival. We evaluated the added prognostic value of residual disease (RD) TILs to Residual Cancer Burden (RCB) in predicting survival post-NAC.

Patients and methods: We combined 4 TNBC NAC patient cohorts who did not achieve pCR. RD TILs were investigated for associations with recurrence-free survival (RFS), and overall survival (OS) using Cox models with stromal TILs as a continuous variable (per 10% increment). The likelihood ratio test was used to evaluate added prognostic value of RD TILs.

Results: 375 RD TNBC samples were evaluable for TILs and RCB. The median age was 50 years, with 62% receiving anthracycline/taxane chemotherapy. The RCB class after NAC was 11%, 50%, 39% for I, II, III respectively. The median RD TIL level was 20% (IQR:10-40). There was a positive correlation between RD TIL levels and CD8+ T cell density (rho=0.41). TIL levels were significantly lower with increasing post-NAC tumor (P=0.005), nodal stage (P=0.032), but did not differ by RCB class (P=0.84). Higher RD TILs were significantly associated with improved RFS (HR:0.86;95%CI 0.79-0.92; P<0.001), and improved OS (HR:0.87;95%CI 0.80-0.94;P<0.001), and remained significant predictors in multivariate analysis (RFS P=0.032; OS P=0.038 for OS). RD TILs added significant prognostic value to multivariate models including RCB class (P<0.001 for RFS; P=0.021 for OS). The positive prognostic effect of RD TILs significantly differed by RCB class for RFS (PInt=0.003) and OS (PInt=0.008), with a greater magnitude of positive effect observed for RCB class II than class III.

Conclusions: TIL levels in TNBC RD are significantly associated with improved RFS and OS and add further prognostic information to RCB class, particularly in RCB class II.

Original languageEnglish
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
DOIs
Publication statusE-pub ahead of print - Dec 27 2018

Fingerprint

Triple Negative Breast Neoplasms
Tumor-Infiltrating Lymphocytes
Residual Neoplasm
Adjuvant Chemotherapy
Survival
Recurrence
Drug Therapy

Cite this

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy. / Luen, S J; Salgado, R; Dieci, M V; Vingiani, A; Curigliano, G; Gould, R E; Castaneda, C; D'Alfonso, T; Sanchez, J; Cheng, E; Andreopoulou, E; Castillo, M; Adams, S; Demaria, S; Symmans, W F; Michiels, S; Loi, S.

In: Annals of oncology : official journal of the European Society for Medical Oncology, 27.12.2018.

Research output: Contribution to journalArticle

Luen, S J ; Salgado, R ; Dieci, M V ; Vingiani, A ; Curigliano, G ; Gould, R E ; Castaneda, C ; D'Alfonso, T ; Sanchez, J ; Cheng, E ; Andreopoulou, E ; Castillo, M ; Adams, S ; Demaria, S ; Symmans, W F ; Michiels, S ; Loi, S. / Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018.
@article{3a5db5cf5711444a85672236c4338067,
title = "Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy",
abstract = "Background: For primary triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NAC), higher pre-treatment tumor-infiltrating lymphocytes (TILs) correlates with increased pathological complete response (pCR) rates, and improved survival. We evaluated the added prognostic value of residual disease (RD) TILs to Residual Cancer Burden (RCB) in predicting survival post-NAC.Patients and methods: We combined 4 TNBC NAC patient cohorts who did not achieve pCR. RD TILs were investigated for associations with recurrence-free survival (RFS), and overall survival (OS) using Cox models with stromal TILs as a continuous variable (per 10{\%} increment). The likelihood ratio test was used to evaluate added prognostic value of RD TILs.Results: 375 RD TNBC samples were evaluable for TILs and RCB. The median age was 50 years, with 62{\%} receiving anthracycline/taxane chemotherapy. The RCB class after NAC was 11{\%}, 50{\%}, 39{\%} for I, II, III respectively. The median RD TIL level was 20{\%} (IQR:10-40). There was a positive correlation between RD TIL levels and CD8+ T cell density (rho=0.41). TIL levels were significantly lower with increasing post-NAC tumor (P=0.005), nodal stage (P=0.032), but did not differ by RCB class (P=0.84). Higher RD TILs were significantly associated with improved RFS (HR:0.86;95{\%}CI 0.79-0.92; P<0.001), and improved OS (HR:0.87;95{\%}CI 0.80-0.94;P<0.001), and remained significant predictors in multivariate analysis (RFS P=0.032; OS P=0.038 for OS). RD TILs added significant prognostic value to multivariate models including RCB class (P<0.001 for RFS; P=0.021 for OS). The positive prognostic effect of RD TILs significantly differed by RCB class for RFS (PInt=0.003) and OS (PInt=0.008), with a greater magnitude of positive effect observed for RCB class II than class III.Conclusions: TIL levels in TNBC RD are significantly associated with improved RFS and OS and add further prognostic information to RCB class, particularly in RCB class II.",
author = "Luen, {S J} and R Salgado and Dieci, {M V} and A Vingiani and G Curigliano and Gould, {R E} and C Castaneda and T D'Alfonso and J Sanchez and E Cheng and E Andreopoulou and M Castillo and S Adams and S Demaria and Symmans, {W F} and S Michiels and S Loi",
year = "2018",
month = "12",
day = "27",
doi = "10.1093/annonc/mdy547",
language = "English",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy

AU - Luen, S J

AU - Salgado, R

AU - Dieci, M V

AU - Vingiani, A

AU - Curigliano, G

AU - Gould, R E

AU - Castaneda, C

AU - D'Alfonso, T

AU - Sanchez, J

AU - Cheng, E

AU - Andreopoulou, E

AU - Castillo, M

AU - Adams, S

AU - Demaria, S

AU - Symmans, W F

AU - Michiels, S

AU - Loi, S

PY - 2018/12/27

Y1 - 2018/12/27

N2 - Background: For primary triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NAC), higher pre-treatment tumor-infiltrating lymphocytes (TILs) correlates with increased pathological complete response (pCR) rates, and improved survival. We evaluated the added prognostic value of residual disease (RD) TILs to Residual Cancer Burden (RCB) in predicting survival post-NAC.Patients and methods: We combined 4 TNBC NAC patient cohorts who did not achieve pCR. RD TILs were investigated for associations with recurrence-free survival (RFS), and overall survival (OS) using Cox models with stromal TILs as a continuous variable (per 10% increment). The likelihood ratio test was used to evaluate added prognostic value of RD TILs.Results: 375 RD TNBC samples were evaluable for TILs and RCB. The median age was 50 years, with 62% receiving anthracycline/taxane chemotherapy. The RCB class after NAC was 11%, 50%, 39% for I, II, III respectively. The median RD TIL level was 20% (IQR:10-40). There was a positive correlation between RD TIL levels and CD8+ T cell density (rho=0.41). TIL levels were significantly lower with increasing post-NAC tumor (P=0.005), nodal stage (P=0.032), but did not differ by RCB class (P=0.84). Higher RD TILs were significantly associated with improved RFS (HR:0.86;95%CI 0.79-0.92; P<0.001), and improved OS (HR:0.87;95%CI 0.80-0.94;P<0.001), and remained significant predictors in multivariate analysis (RFS P=0.032; OS P=0.038 for OS). RD TILs added significant prognostic value to multivariate models including RCB class (P<0.001 for RFS; P=0.021 for OS). The positive prognostic effect of RD TILs significantly differed by RCB class for RFS (PInt=0.003) and OS (PInt=0.008), with a greater magnitude of positive effect observed for RCB class II than class III.Conclusions: TIL levels in TNBC RD are significantly associated with improved RFS and OS and add further prognostic information to RCB class, particularly in RCB class II.

AB - Background: For primary triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NAC), higher pre-treatment tumor-infiltrating lymphocytes (TILs) correlates with increased pathological complete response (pCR) rates, and improved survival. We evaluated the added prognostic value of residual disease (RD) TILs to Residual Cancer Burden (RCB) in predicting survival post-NAC.Patients and methods: We combined 4 TNBC NAC patient cohorts who did not achieve pCR. RD TILs were investigated for associations with recurrence-free survival (RFS), and overall survival (OS) using Cox models with stromal TILs as a continuous variable (per 10% increment). The likelihood ratio test was used to evaluate added prognostic value of RD TILs.Results: 375 RD TNBC samples were evaluable for TILs and RCB. The median age was 50 years, with 62% receiving anthracycline/taxane chemotherapy. The RCB class after NAC was 11%, 50%, 39% for I, II, III respectively. The median RD TIL level was 20% (IQR:10-40). There was a positive correlation between RD TIL levels and CD8+ T cell density (rho=0.41). TIL levels were significantly lower with increasing post-NAC tumor (P=0.005), nodal stage (P=0.032), but did not differ by RCB class (P=0.84). Higher RD TILs were significantly associated with improved RFS (HR:0.86;95%CI 0.79-0.92; P<0.001), and improved OS (HR:0.87;95%CI 0.80-0.94;P<0.001), and remained significant predictors in multivariate analysis (RFS P=0.032; OS P=0.038 for OS). RD TILs added significant prognostic value to multivariate models including RCB class (P<0.001 for RFS; P=0.021 for OS). The positive prognostic effect of RD TILs significantly differed by RCB class for RFS (PInt=0.003) and OS (PInt=0.008), with a greater magnitude of positive effect observed for RCB class II than class III.Conclusions: TIL levels in TNBC RD are significantly associated with improved RFS and OS and add further prognostic information to RCB class, particularly in RCB class II.

U2 - 10.1093/annonc/mdy547

DO - 10.1093/annonc/mdy547

M3 - Article

C2 - 30590484

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -